Drs Brinton and Michos highlight LDL-C apheresis in the treatment landscape for homozygous familial hypercholesterolemia [HoFH]. Eliot Brinton, MD: What do we do if the standard treatments don’t work?

An acute reduction in total cholesterol of ≥65%, or in LDL cholesterol of ≥70%, during each procedure; An interval mean total cholesterol of <7 mmol/l or LDL cholesterol <6.5 mmol/l (or decreases of ...

Bethesda, MD - A small study from Japan entitled the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART) suggests that aggressive lipid-lowering therapy using a ...

LDL stands for low-density lipoproteins. LDL is commonly known as the “bad” cholesterol. LDL apheresis is a treatment that removes bad cholesterol from the blood. Many people can treat high ...

Please provide your email address to receive an email when new articles are posted on . Evolocumab effectively lowered plasma LDL in patients with homozygous or severe heterozygous familial ...

Q: I’ve heard I can have my high cholesterol filtered out of my blood, just like kidney dialysis. Is that true? — Jamie C., Chicago A: Yes and no. There’s a treatment called LDL apheresis that’s ...

Evinacumab (Regeneron), a fully human monoclonal antibody inhibitor of angiopoietin-like protein 3 (ANGPTL3), substantially lowers LDL cholesterol in patients with homozygous familial ...

Findings from the APH-19 trial showed lomitapide-treated patients experienced a 49% mean reduction in LDL-C from baseline at week 24. The Food and Drug Administration (FDA) has expanded the approval ...

B. Braun Medical’s renal therapies division has announced the availability of the Plasmat Futura System for heparin-induced extracorporeal lipoprotein precipitation (HELP) LDL Apheresis therapy. HELP ...

Homozygous familial hypercholesterolemia (HoFH) is an insidious disease. People so afflicted are born without low density lipoprotein (LDL) receptors – the receptors that are responsible for clearing ...

A staggering 28 million adults in the United States have high cholesterol, meaning they have too many lipids (fats) in their blood. That number, from the Centers for Disease Control and Prevention ...

LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, has entered into a business relationship with Kaneka, a global leader ...